$147.04
1.430.98%
Last update: 10:49 AM
15 minutes delayed
Comments
Loading...
Sarepta Therapeutics
SRPTNASDAQ
Latest news for Sarepta Therapeutics (NASDAQ:SRPT) Stock
Sarepta Therapeutics Stock (NASDAQ: SRPT)
Categories: All
Thursday, July 18, 2024
Wednesday, July 17, 2024
Thursday, July 04, 2024
Monday, July 01, 2024
Thursday, June 27, 2024
Wednesday, June 26, 2024
Monday, June 24, 2024
- Here's How Much You Would Have Made Owning Sarepta Therapeutics Stock In The Last 10 Years
- Morgan Stanley Maintains Overweight on Sarept...
- Sarepta Therapeutics shares are trading highe...
- Evercore ISI Group Maintains In-Line on Sarep...
- Micron To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Monday
- BMO Capital Maintains Outperform on Sarepta T...
- Leerink Partners Maintains Outperform on Sare...
Sunday, June 23, 2024
Friday, June 21, 2024
- Growth Stocks Leave Value Stocks In The Dust: 4 Reasons For Biggest Monthly Lead In Over A Year
- Nasdaq Moves Lower; FactSet Research Posts Upbeat Earnings
- Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Morgan Stanley Reiterates Overweight on Sarep...
- Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty
- Stocks Stall As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?
- Piper Sandler Maintains Overweight on Sarepta...
- Sarepta's Expanded FDA Approval For Elevidys Potentially Shaping Future FDA Reviews, Analyst Says
- Gold Down 1%; CarMax Shares Gain After Q1 Earnings
- Cantor Fitzgerald Reiterates Neutral on Sarep...
- Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
- Barclays Maintains Overweight on Sarepta Ther...
- Apple To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday
- Sarepta Therapeutics CEO Says Have No Intenti...
- Market-Moving News for June 21st
- Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
- Sarepeta Therapeutics shares are trading high...
- Wall Street Looks Set For Modestly Lower Start Ahead Of Key Data, Tech Stocks Muted In Premarket: Analyst Says 'Bearish Sentiment Has Become Understandably Quiet'
- Baird Maintains Outperform on Sarepta Therape...
- RBC Capital Maintains Sector Perform on Sarep...
- B of A Securities Maintains Buy on Sarepta Th...
- Needham Maintains Buy on Sarepta Therapeutics...